Credits Available: 4.25 AMA PRA Category 1 Credit™/ MOC Points

Description: This dynamic course focuses on the exchange of best practices regarding the use of bispecifics in patients with R/R DLBCL including patient eligibility. Through this interactive, small-group activity, participants will review brief modules and patient cases to identify signs and symptoms of toxicities experienced while receiving treatment with bispecific antibodies for R/R DLBCL and also integrate protocols to manage CRS and ICANS effectively when managing patients. The group will gather for a live discussion via Zoom to share and exchange ideas on this topic.

CME/CE Accreditation Information

If you already have a Gather-ed account, please login

Email:
Password:

Register

Step 1 of 3

This program is intended for:
Target Professions: DO, MD, Nurse, Nurse Practitioner, Pharmacist, Physician Assistant
Target Specialties: Hematology, Hematology/Oncology, Oncology

Amanda Chron

Memorial Sloan Kettering
Clinical Pharmacy Specialist

Amanda Chron, PharmD, MS is a lymphoma clinical pharmacy specialist at Memorial Sloan Kettering Cancer Center. She completed both her Doctor of Pharmacy and master’s degrees at the University of Southern California and went on to complete her PGY-1 residency at Brigham and Women’s Hospital. She then completed her PGY-2 training at Memorial Sloan Kettering Cancer Center and is currently in her second year of practice post-residency, practicing in both the inpatient and outpatient settings.